He Zhifang, Li Wenyu
Shanghai Xuhui Area Government of Community Office of Kangjian Xincun Street, Shanghai, People's Republic of China.
School of Marxism, Capital Normal University, Beijing, People's Republic of China.
Diabetes Metab Syndr Obes. 2025 Jan 8;18:85-92. doi: 10.2147/DMSO.S495364. eCollection 2025.
With the aging of China's population and lifestyle changes, the number of patients with type 2 diabetes (T2D) has surged, posing a significant challenge to the public health system. This study explores the application and effectiveness of artificial intelligence (AI) technology in T2D management from a Chinese perspective. AI demonstrates substantial potential in personalized treatment planning, real-time monitoring and early warning, telemedicine, and health management. It not only enhances the precision and convenience of treatment but also aids in preventing and managing complications. Despite challenges in data privacy, technology popularization, standardization, and regulation, AI technology's continuous maturation and expanded application suggest its increasingly pivotal role in T2D management. In the future, through interdepartmental collaboration, policy support, and cultural adaptation, AI is poised to bring revolutionary changes to diabetes management in China and globally.
随着中国人口老龄化和生活方式的改变，2型糖尿病（T2D）患者数量激增，给公共卫生系统带来了巨大挑战。本研究从中国视角探讨人工智能（AI）技术在T2D管理中的应用及效果。人工智能在个性化治疗方案制定、实时监测与预警、远程医疗及健康管理方面展现出巨大潜力。它不仅提高了治疗的精准性和便利性，还有助于预防和管理并发症。尽管在数据隐私、技术普及、标准化及监管方面存在挑战，但人工智能技术的不断成熟和应用范围的扩大表明其在T2D管理中发挥着越来越关键的作用。未来，通过跨部门协作、政策支持及文化适应，人工智能有望给中国乃至全球的糖尿病管理带来变革性变化。
